subject: Haematology Global Market Briefing to 2016 [print this page] Haematology Global Market Briefing to 2016
Report Reserve announces inclusion of a new market research report to its premium store.
GlobalData's new report, "Haematology Global Market Briefing to 2016" provides key data, information and analysis on the global haematology market. The report provides market landscape, competitive landscape and market trends information on the haematology market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
The Global Haematology Market is expected to grow at a CAGR of 5% from 20092016
The global haematology market is expected to grow at 5.1% in 20092016 to reach $7,699m by 2016. Haemostasis is forecast to grow at 4.6% CAGR to reach $2,233m in 2016. The haematology reagents segment is expected to reach $1,781m in 2016, and is forecast to grow at 5.8% during 20092016. Immunohaematology is expected to grow at 5.1% during 20092016, and is expected to reach $1,491m in 2016. Haematology analyzers and haematology cell counter segments are expected to grow at 5.8% and 2.4% respectively in 20092016 and are forecast to grow to $797m and $554m respectively. Haematology rapid tests market is expected grow at 5.8% during the same period and is forecast to reach $843m.
Advances in rapid test technology and the introduction of high sensitivity point of care tests will drive the growth in the global haematology market. For instance, Inverness Medical Innovations is developing rapid diagnostic tests for detecting the viral load for HIV in blood. Commercialization of innovative products is likely to drive the future growth in the category.
Emerging Countries Expected to Drive Haematology Category in the Future
Haematology markets in China, India and Brazil are expected to grow at higher than average rates of 16%, 15% and 14% respectively. This is likely to drive the growth in the global haematology market. The growth in the emerging countries will be driven by the continued growing affordability and rising healthcare expenditure in the countries. Unlike industrialized nations in North America and Europe, the emerging nations have remained less impacted by the recession, and are expected to witness a healthy Gross Domestic Product (GDP) growth over the next few years. This will be reflected in the improved affordability in the masses, and consequent shift in expenditure towards healthcare. Several government initiatives to improve healthcare for the masses will also result in increased healthcare expenditure.
Technological Advances to Drive Adoption of Next Generation Hematology Testing
Innovations in microfluidics and biosensor technology are enabling reduction in the blood sample needed to conduct tests and at the same time improving sensitivity and reducing the time taken to conduct the test. These tests are expected to drive the POC testing market for haematology, and reduce dependence on central laboratory testing. For instance, BrightSPOT currently under product development by Beacon
Biotechnology is a disposable diagnostic device capable of diagnosing 112 different diseases in a single drop of body fluid within 15 minutes. Another product which is currently in early development is a biochip system for point-of-care blood cell analysis. The system features a detector programmed to search for various proteins or amino acids from viruses or bacteria associated with different diseases. Point of Care Testing device being developed by Philips Research and bioMerieux Sa is based on Magnotech biosensor technology to aid early diagnosis in critical care settings. The technology is integrated into a disposable biosensor cartridge that can be inserted into a hand-held analyzer. It uses magnetic nanoparticles to measure target molecules in very low (picomolar) concentrations in blood or saliva in just a few minutes. For more details, please vist http://www.reportreserve.com/reportdet.php?company=GlobalData&reportid=13220
welcome to Insurances.net (https://www.insurances.net)
